DarioHealth (NASDAQ: DRIO), a pioneer in the global digital-therapeutics market, today announced that Vitality Group has chosen the company’s digital therapeutics solutions for inclusion in Vitality’s new Gateway Flex offering. According to the update, Gateway Flex enables employers to personalize the health-care experience to meet the diverse and rapidly changing needs of their employees and … Continue reading “NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Platform Selected for Integration in Vitality’s Gateway Flex”
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital-therapeutics market, together with HMC HealthWorks, a 40-year veteran in health-care management with clinically-integrated models of care that reduce health-care costs and improve population health, today announced entry into a sales and distribution agreement. Under the partnership, HMC will incorporate DarioHealth’s digital therapeutics solution into its care … Continue reading “NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) and HMC HealthWorks Enter Sales and Distribution Partnership”
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital-therapeutics market, today announced that Eric Milledge has joined DarioHealth as chairman of the company’s newly-established Scientific Advisory Board (“SAB”). Milledge has dedicated his entire career to the field of health care, with a focus on pharmaceuticals and medical devices, and spent 34 years at Johnson & … Continue reading “NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Strategic Scientific Advisory Board Appointment”
DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, has recently achieved a series of successes and anticipates even more in the coming weeks. Among drivers of DRIO’s path toward leading cutting-edge solutions is the global pandemic, which has unveiled dynamics of the company’s business model that provide distinction in … Continue reading “NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) CEO Discusses Transformation to B2B2C Digital Therapeutics”
DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, recently completed a round of successful fundraising that will assist in expanding the availability of its platform. DarioHealth secured approximately $28.6 million in aggregate gross proceeds from health-care funds and institutions across the United States and Israel through the private-placement transaction … Continue reading “NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Positioned to Compete in ‘Largely Untapped US Market’”
DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, is a clear point-of-need innovator in today’s standoffish environment. The company supplies hospitals with next-generation technology to provide patients necessary care as they are “roomed” at home under a remote-monitoring regimen. A recent article discussing this reads, “DarioHealth’s Remote Patient Monitoring … Continue reading “NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Taking Health Care Home Through Innovative Platform”
Shares of DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, reached a new 52-week high on Wednesday. In morning trading, the company’s shares reached a peak of $22.49 on volume of over 170,000, up from an opening price of $18.75. At time of publishing, shares of DRIO hover around $21.35, marking … Continue reading “NetworkNewsBreaks – Shares of DarioHealth Corp. (NASDAQ: DRIO) Reach 52-Week High”
DarioHealth Corp. reported its second quarter financial results Aug. 12, showing a revenue increase on a quarter-to-quarter basis, as well as gross profit increases of 95 percent and 60 percent on year-over-year quarterly and six-month measures, respectively CEO Erez Raphael recently appeared on Fox Business news forum “The Claman Countdown” to discuss the company’s health … Continue reading “DarioHealth Corp. (NASDAQ: DRIO) Beats Street Q2 Revenue Estimates by 20% and Reveals Late Stage, Virtual Healthcare, B2B2C Sales Pipeline”
Aegis Capital Corp. has initiated coverage with a ‘Buy’ rating and price target of $25 on shares of DarioHealth’s (NASDAQ: DRIO) stock. DRIO is a pioneer in the global digital therapeutics (“DTx”) industry with its popular, smartphone-centered personalized chronic illness management software-as-a-service (SaaS). The report reads, “We initiate coverage on DRIO with a BUY rating … Continue reading “NetworkNewsBreaks – Aegis Capital Corp. Initiates Coverage, Issues ‘Buy’ Rating on DarioHealth Corp. (NASDAQ: DRIO)”
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has released a business update, including financial numbers and corporate achievements for the second quarter ended June 30, 2020. Highlights of the report include the company’s announcement of two Remote Patient Monitoring (“RPM”) agreements in the United States as well as an agreement with … Continue reading “NetworkNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q2 Revenue, Overview of Key Company Highlights and Development”
